Alzheimer’s Society and Professor Sir John Hardy respond to results for Alzheimer’s drug lecanemab: A paper published today in The New England Journal of Medicine has shown that lecanemab, a drug being tested in people with early Alzheimer’s disease, showed a statistically significant reduction in cognitive decline – changes in thinking and memory associated with […]
Dr Greg Elder, Senior Lecturer in Psychology and Associate Director of Northumbria Sleep Research explores why a good night’s sleep is important and how our sleeping patterns can be linked to conditions like dementia for The Conversation. A good night’s sleep is important for many reasons. It helps our body repair itself and function as […]
Read More… from Sleeping longer than 6.5 hours associated with cognitive decline
Enhanced lifestyle counselling prevents cognitive decline even in people who are carriers of the APOE4 gene, a common risk factor of Alzheimer’s disease, according to a new study published in JAMA Neurology. The two-year FINGER trial involved 60–77 year-old people living in Finland and with risk factors for memory disorders. The study participants were divided […]
Read More… from Lifestyle counselling prevents cognitive decline
Our research has found a link between gum disease and greater rates of cognitive decline in people with early stages of Alzheimer’s Disease. Periodontitis or gum disease is common in older people and may become more common in Alzheimer’s disease because of a reduced ability to take care of oral hygiene as the disease progresses. Higher levels of antibodies […]
Read More… from Failing to brush your teeth properly could accelerate Alzheimer’s